![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CYTL1 mRNA | CTD | PMID:30723492 | 17beta-estradiol | decreases expression | ISO | RGD:1615683 | 6480464 | Estradiol results in decreased expression of CYTL1 mRNA | CTD | PMID:19484750 | 17beta-estradiol | increases expression | ISO | RGD:1351161 | 6480464 | Estradiol results in increased expression of CYTL1 mRNA | CTD | PMID:25878060 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1351161 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYTL1 mRNA | CTD | PMID:21998131 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | RGD:1351161 | 6480464 | 2 more ... | CTD | PMID:26705709 | 2-methylcholine | affects expression | ISO | RGD:1351161 | 6480464 | beta-methylcholine affects the expression of CYTL1 mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:1615683 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CYTL1 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1351161 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of CYTL1 mRNA | CTD | PMID:27685785 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1615683 | 6480464 | Fenretinide results in decreased expression of CYTL1 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of CYTL1 mRNA | CTD | PMID:24780913 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of CYTL1 mRNA | CTD | PMID:28959563 | all-trans-retinoic acid | decreases expression | ISO | RGD:1351161 | 6480464 | Tretinoin results in decreased expression of CYTL1 mRNA | CTD | PMID:15894607 more ... | all-trans-retinoic acid | multiple interactions | ISO | RGD:1351161 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of CYTL1 mRNA | CTD | PMID:15894607 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of CYTL1 mRNA | CTD | PMID:30779732 | arsenous acid | multiple interactions | ISO | RGD:1351161 | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CYTL1 mRNA, Arsenic Trioxide inhibits the reaction [SP1 protein binds to CYTL1 promoter] | CTD | PMID:15761015, PMID:15894607 | arsenous acid | decreases expression | ISO | RGD:1351161 | 6480464 | Arsenic Trioxide results in decreased expression of CYTL1 mRNA | CTD | PMID:15070760 more ... | benzo[a]pyrene | affects methylation | ISO | RGD:1351161 | 6480464 | Benzo(a)pyrene affects the methylation of CYTL1 3' UTR more ... | CTD | PMID:27901495, PMID:30157460 | benzo[b]fluoranthene | decreases expression | ISO | RGD:1615683 | 6480464 | benzo(b)fluoranthene results in decreased expression of CYTL1 mRNA | CTD | PMID:26377693 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CYTL1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYTL1 mRNA | CTD | PMID:30816183, PMID:32528016 | bisphenol A | increases expression | ISO | RGD:1351161 | 6480464 | bisphenol A results in increased expression of CYTL1 mRNA | CTD | PMID:27685785 | C60 fullerene | affects expression | EXP | | 6480464 | fullerene C60 affects the expression of CYTL1 mRNA | CTD | PMID:19167457 | carbamazepine | affects expression | ISO | RGD:1351161 | 6480464 | Carbamazepine affects the expression of CYTL1 mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | RGD:1615683 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cobalt dichloride | decreases expression | ISO | RGD:1351161 | 6480464 | cobaltous chloride results in decreased expression of CYTL1 mRNA | CTD | PMID:19320972 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of CYTL1 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of CYTL1 mRNA | CTD | PMID:30556269 | deoxynivalenol | decreases expression | ISO | RGD:1351161 | 6480464 | deoxynivalenol results in decreased expression of CYTL1 mRNA | CTD | PMID:31863870 | diarsenic trioxide | decreases expression | ISO | RGD:1351161 | 6480464 | Arsenic Trioxide results in decreased expression of CYTL1 mRNA | CTD | PMID:15070760 more ... | diarsenic trioxide | multiple interactions | ISO | RGD:1351161 | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CYTL1 mRNA, Arsenic Trioxide inhibits the reaction [SP1 protein binds to CYTL1 promoter] | CTD | PMID:15761015, PMID:15894607 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of CYTL1 mRNA | CTD | PMID:21551480 | dorsomorphin | multiple interactions | ISO | RGD:1351161 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | folic acid | decreases expression | ISO | RGD:1615683 | 6480464 | Folic Acid results in decreased expression of CYTL1 mRNA | CTD | PMID:25629700 | fonofos | increases methylation | ISO | RGD:1351161 | 6480464 | Fonofos results in increased methylation of CYTL1 promoter | CTD | PMID:22847954 | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of CYTL1 mRNA | CTD | PMID:25539665 | hydrogen peroxide | decreases expression | ISO | RGD:1351161 | 6480464 | Hydrogen Peroxide results in decreased expression of CYTL1 mRNA | CTD | PMID:15761015 | nickel atom | decreases expression | ISO | RGD:1351161 | 6480464 | Nickel results in decreased expression of CYTL1 mRNA | CTD | PMID:24768652, PMID:25583101 | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of CYTL1 mRNA | CTD | PMID:28623178 | ozone | multiple interactions | ISO | RGD:1615683 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CYTL1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYTL1 mRNA | CTD | PMID:34911549 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of CYTL1 mRNA | CTD | PMID:32680482 | parathion | increases methylation | ISO | RGD:1351161 | 6480464 | Parathion results in increased methylation of CYTL1 promoter | CTD | PMID:22847954 | perfluorononanoic acid | increases expression | ISO | RGD:1351161 | 6480464 | perfluoro-n-nonanoic acid results in increased expression of CYTL1 mRNA | CTD | PMID:25812627 | perfluorooctanoic acid | increases expression | ISO | RGD:1351161 | 6480464 | perfluorooctanoic acid results in increased expression of CYTL1 mRNA | CTD | PMID:25812627 | reactive oxygen species | affects expression | ISO | RGD:1351161 | 6480464 | Reactive Oxygen Species affects the expression of CYTL1 mRNA | CTD | PMID:15761015 | SB 431542 | multiple interactions | ISO | RGD:1351161 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | serpentine asbestos | decreases expression | ISO | RGD:1615683 | 6480464 | Asbestos, Serpentine results in decreased expression of CYTL1 mRNA | CTD | PMID:21514415 | T-2 toxin | decreases expression | ISO | RGD:1351161 | 6480464 | T-2 Toxin results in decreased expression of CYTL1 mRNA | CTD | PMID:31863870 | terbufos | increases methylation | ISO | RGD:1351161 | 6480464 | terbufos results in increased methylation of CYTL1 promoter | CTD | PMID:22847954 | titanium dioxide | decreases expression | ISO | RGD:1615683 | 6480464 | titanium dioxide results in decreased expression of CYTL1 mRNA | CTD | PMID:23409001 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of CYTL1 mRNA | CTD | PMID:30012374 | titanium dioxide | affects expression | ISO | RGD:1615683 | 6480464 | titanium dioxide affects the expression of CYTL1 mRNA | CTD | PMID:23557971 | trichostatin A | increases expression | ISO | RGD:1351161 | 6480464 | trichostatin A results in increased expression of CYTL1 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1351161 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYTL1 mRNA | CTD | PMID:27188386 | triclosan | increases expression | ISO | RGD:1351161 | 6480464 | Triclosan results in increased expression of CYTL1 mRNA | CTD | PMID:30510588 | valproic acid | affects expression | ISO | RGD:1351161 | 6480464 | Valproic Acid affects the expression of CYTL1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RGD:1351161 | 6480464 | Valproic Acid results in increased expression of CYTL1 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RGD:1351161 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYTL1 mRNA | CTD | PMID:27188386 | vorinostat | multiple interactions | ISO | RGD:1351161 | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYTL1 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | RGD:1351161 | 6480464 | vorinostat results in increased expression of CYTL1 mRNA | CTD | PMID:26272509 | |